Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.25M Buy
8,608
+44
+0.5% +$6.08K 0.38% 61
2026
Q2
$1.12M Sell
8,564
-1,309
-13% -$153K 0.34% 67
2026
Q1
$1.19M Buy
9,873
+1,946
+25% +$225K 0.42% 54
2025
Q4
$834K Sell
7,927
-1,796
-18% -$169K 0.27% 80
2025
Q3
$816K Buy
9,723
+97
+1% +$7.99K 0.33% 66
2025
Q2
$762K Buy
9,626
+2,177
+29% +$173K 0.35% 68
2025
Q1
$669K Buy
7,449
+3,523
+90% +$329K 0.33% 80
2024
Q4
$391K Buy
+3,926
New +$405K 0.2% 98

Other funds holding MRK

Argentarii's MRK Position: Q3 2026 in Review

Argentarii increased its Merck (MRK) stake by 0.51% in Q3 2026, buying an estimated $6.08K and bringing the position to 8,608 shares worth $1.25M. The position accounts for 0.38% of the portfolio, ranked #61.

Argentarii first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 1,788 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Argentarii held 8,608 shares of Merck worth $1.25M as of Q3 2026.
  • Argentarii bought 44 Merck shares in Q3 2026, an estimated $6.08K.
  • Merck made up 0.38% of Argentarii's portfolio in Q3 2026, its #61 holding.
  • Argentarii first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 1,788 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Argentarii's 13F filing for Q3 2026, filed 28 Oct 2026.